home / stock / azn / azn articles

AZN Articles, AstraZeneca PLC - From 12/26/23

Stock Information
Company Name: AstraZeneca PLC
Stock Symbol: AZN
Market: NYSE
Website: astrazeneca.com
Menu
AZN AZN Quote AZN Short AZN News AZN Articles AZN Message Board
Get AZN Alerts

News, Short Squeeze, Breakout and More Instantly...
Nasdaq Surges 75 Points; Inspira Technologies Shares Spike Higher | Benzinga

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 150 points on Tuesday. The Dow traded up 0.50% to 3...
Crude Oil Rises Over 3%; US Home Prices Increase In October | Benzinga

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 100 points on Tuesday. The Dow traded up 0.34% to 37,5...

Evaluating AstraZeneca Against Peers In Pharmaceuticals Industry | Benzinga

In today's rapidly changing and highly competitive business world, it is vital for investors and industry enthusiasts to carefully assess comp...

Health Care Company AstraZeneca Announces Acquisition of Gracell Biotechnologies | Benzinga

AstraZeneca (NASDAQ:AZN) has announced an acquisition of Gracell Biotechnologies (NASDAQ:GRCL) that is expected to be completed in Q1 of 2024. Unde...
US Stocks Set To Start Final Trading Week Of Year On Positive Note As Santa Claus Rally Gets Going: Analyst Confident Of Market Finishing Year At Highs | Benzinga

The Santa Claus rally period is poised to continue on a positive note, with index futures pointing to a modestly higher opening on Tuesday. The mar...

AstraZeneca Bolsters Cell Therapy Pipeline With Over $1B Deal For China-Based Gracell Biotechnologies | Benzinga

AstraZeneca Plc (NASDAQ: AZN) has agreed to acquire Gracell Biotechnologies Inc (NASDAQ: GRCL), further strengthening AstraZeneca...

Pricing Projections And Market Potential For Ionis' Newly Approved Nerve Damage Drug - Analyst Sees Over $700M Potential | Benzinga

Friday, the FDA approved AstraZeneca Plc (NASDAQ: AZN) and Ionis Pharmaceuticals Inc's (NASDAQ: IONS) Wainua (eplontersen) ...
New Hope for Nerve Damage Patients as AstraZeneca/Ionis' Eplontersen Receives FDA Nod for Hereditary Amyloidosis Treatment | Benzinga

Friday, FDA approved AstraZeneca Plc (NASDAQ: AZN) and Ionis Pharmaceuticals Inc's (NASDAQ: IONS) Wainua (eplonte...

Fusion's Pharma's Targeted Cancer Therapy Potential Gets This Analyst Bullish, Sees 100% Upside | Benzinga

RBC Capital Markets initiated coverage on Fusion Pharmaceuticals Inc (NASDAQ: FUSN), saying the radiopharmaceutical industry is a bu...

COVAX Global Initiative For COVID-19 Vaccines Comes To An End Amid Shift To Regular Programs | Benzinga

COVAX, the multilateral mechanism for equitable global access to COVID-19 vaccines launched in 2020, will close on 31 December 2023. ...
Previous 10 Next 10